Download Files:
TLR7/8 agonist 3
$350 – $2,500
Products Details
Product Description
– TLR7/8 agonist 3 is a potent TLR7 and TLR8 agonist, extracted from patent WO2016057618 (compound of formula (II))[1].
Web ID
– HY-130797
Storage Temperature
– -20°C, 3 years; 4°C, 2 years (Powder)
Shipping
– Room Temperature
Applications
– Cancer-programmed cell death
Molecular Formula
– C17H23N5O
References
– [1]Martha A. MILLER, et al. Vaccine compositions and methods of use to treat neonatal subjects.
CAS Number
– 642473-95-8
Molecular Weight
– 313.40
Compound Purity
– 99.02
SMILES
– NC(C)(C)CN1C(COCC)=NC2=C1C3=CC=CC=C3N=C2N
Clinical Information
– No Development Reported
Research Area
– Cancer
Solubility
– DMSO : 50 mg/mL (ultrasonic)
Target
– Toll-like Receptor (TLR)
Isoform
– TLR7;TLR8
Pathway
– Immunology/Inflammation
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
